The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Meta-Analysis of Antibiotics and the Risk of Community-Associated Clostridium difficile Infection
Open accessAbstract
The rising incidence of Clostridium difficile infection (CDI) could be reduced by lowering exposure to high-risk antibiotics. The objective of this study was to determine the association between antibiotic class and the risk of CDI in the community setting. The EMBASE and PubMed databases were queried without restriction to time period or language. Comparative observational studies and randomized controlled trials (RCTs) considering the impact of exposure to antibiotics on CDI risk among nonhospitalized populations were considered. We estimated pooled odds ratios (OR) for antibiotic classes using random-effect meta-analysis. Our search criteria identified 465 articles, of which 7 met inclusion criteria; all were observational studies. Five studies considered antibiotic risk relative to no antibiotic exposure: clindamycin (OR = 16.80; 95% confidence interval [95% CI], 7.48 to 37.76), fluoroquinolones (OR = 5.50; 95% CI, 4.26 to 7.11), and cephalosporins, monobactams, and carbapenems (CMCs) (OR = 5.68; 95% CI, 2.12 to 15.23) had the largest effects, while macrolides (OR = 2.65; 95% CI, 1.92 to 3.64), sulfonamides and trimethoprim (OR = 1.81; 95% CI, 1.34 to 2.43), and penicillins (OR = 2.71; 95% CI, 1.75 to 4.21) had lower associations with CDI. We noted no effect of tetracyclines on CDI risk (OR = 0.92; 95% CI, 0.61 to 1.40). In the community setting, there is substantial variation in the risk of CDI associated with different antimicrobial classes. Avoidance of high-risk antibiotics (such as clindamycin, CMCs, and fluoroquinolones) in favor of lower-risk antibiotics (such as penicillins, macrolides, and tetracyclines) may help reduce the incidence of CDI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
Conducting Meta-Analyses in R with the metafor Package
Viechtbauer, W. (2010) · Journal of Statistical Software · doi:10.18637/jss.v036.i03 · Cited by 20,464 · cited 1×
“Analyses were conducted in R using the meta and metafor packages (25).”
MethodVandenbroucke, J. P., von Elm, E., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., Egger, M., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040297 · Cited by 8,613
Downs, S. H., & Black, N. (1998) · Journal of Epidemiology and Community Health · doi:10.1136/jech.52.6.377 · Cited by 8,252
Feature Selection with the Boruta Package
Kursa, M. B., & Rudnicki, W. R. (2010) · Journal of Statistical Software · doi:10.18637/jss.v036.i11 · Cited by 5,659
Vandenbroucke, J. P., Elm, E. V., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., Egger, M., & initiative, F. T. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00010-w1 · Cited by 3,543
Sanderson, S., Tatt, I. D., & Higgins, J. P. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym018 · Cited by 1,531
Meta-analysis Spurious precision? Meta-analysis of observational studies
Egger, M., Schneider, M., & Smith, G. D. (1998) · BMJ · doi:10.1136/bmj.316.7125.140 · Cited by 997
Davies, H. T. O., Crombie, I. K., & Tavakoli, M. (1998) · BMJ · doi:10.1136/bmj.316.7136.989 · Cited by 984
Risk factors for Clostridium difficile infection
Bignardi, G. E. (1998) · Journal of Hospital Infection · doi:10.1016/s0195-6701(98)90019-6 · Cited by 647
Antimicrobial‐Associated Risk Factors for Clostridium difficile Infection
Owens, Jr., Donskey, C. J., Gaynes, R. P., Loo, V. G., & Muto, C. A. (2008) · Clinical Infectious Diseases · doi:10.1086/521859 · Cited by 603 · cited 1×
“This could be expected given the broad spectrum of activity of these agents against intestinal microbes and the low susceptibility of Clostridium difficile to these classes of antibiotics (30).”
BackgroundSystematic reviews and meta-analyses: an illustrated, step-by-step guide.
Pai, M., McCulloch, M., Gorman, J. D., Pai, N. P., Enanoria, W. T. A., Kennedy, G., Tharyan, P., & Colford, J. M. (2004) · PubMed · Cited by 521
Cumulative Antibiotic Exposures Over Time and the Risk of Clostridium difficile Infection
Stevens, V., Dumyati, G., Fine, L. S., Fisher, S. G., & van Wijngaarden, E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir301 · Cited by 446
A case-control study of community-associated Clostridium difficile infection
Wilcox, M. H., Mooney, L., Bendall, R., Settle, C. D., & Fawley, W. N. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn163 · Cited by 372
Carratalà, J., Mykietiuk, A., Fernández-Sabé, N., Suárez, C., Dorca, J., Verdaguer, R., Manresa, F., & Gudiol, F. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.13.1393 · Cited by 323
Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review
Thomas, C. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg254 · Cited by 305
&NA; (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000202057.19407.4d · Cited by 271
The distribution of Clostridium difficile in the environment of South Wales
Al Saif, N., & BRAZIER, J. S. (1996) · Journal of Medical Microbiology · doi:10.1099/00222615-45-2-133 · Cited by 259
Clostridium difficile in Retail Ground Meat, Canada
Rodriguez-Palacios, A., Staempfli, H. R., Duffield, T., & Weese, J. S. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1303.060988 · Cited by 254
Epidemiology of Community-Acquired Clostridium difficile-Associated Diarrhea
Hirschhorn, L. R., Trnka, Y., Onderdonk, A., Lee, M.-L. T., & Platt, R. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/169.1.127 · Cited by 237
Hecht, D. W., Galang, M. A., Sambol, S. P., Osmolski, J. R., Johnson, S., & Gerding, D. N. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01623-06 · Cited by 228
Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection
Dial, S., Kezouh, A., Dascal, A., Barkun, A., & Suissa, S. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.071812 · Cited by 166
(2005) · PubMed · Cited by 164
Kuntz, J. L., Chrischilles, E. A., Pendergast, J. F., Herwaldt, L. A., & Polgreen, P. M. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-194 · Cited by 161
Lowe, D. O., Mamdani, M. M., Kopp, A., Low, D. E., & Juurlink, D. N. (2006) · Clinical Infectious Diseases · doi:10.1086/508453 · Cited by 156
Dubberke, E. R. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.10.1092 · Cited by 141
On Logit Confidence Intervals for the Odds Ratio with Small Samples
Agresti, A. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.00597.x · Cited by 115
Bauer, M. P., Veenendaal, D., Verhoef, L., Bloembergen, P., van Dissel, J. T., & Kuijper, E. J. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02853.x · Cited by 100
Naggie, S., Miller, B. A., Zuzak, K. B., Pence, B. W., Mayo, A., Nicholson, B. P., Kutty, P. K., McDonald, L. C., & Woods, C. W. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.10.013 · Cited by 96
Antibiotics and Clostridium difficile diarrhea in the ambulatory care setting
Levy, D. G., Stergachis, A. S., McFarland, L. V., Vorst, K. V., Graham, D. J., Johnson, E. S., Park, B., Shatin, D., Clause, J. C., & Elmer, G. W. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)87980-1 · Cited by 87
Pultz, N. J., & Donskey, C. J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3529-3532.2005 · Cited by 75
Miyajima, F., Roberts, P., Swale, A., Price, V., Jones, M., Horan, M. A., Beeching, N. J., Brazier, J. S., Parry, C., Pendleton, N., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022804 · Cited by 65
Are Broad-Spectrum Fluoroquinolones More Likely To Cause Clostridium difficile -Associated Disease?
Dhalla, I. A., Mamdani, M., Simor, A. E., Kopp, A., Rochon, P. A., & Juurlink, D. N. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00592-06 · Cited by 48
Baillie, L., & Thomas, L. H. (2009) · doi:10.1201/b13420-25 · Cited by 44
Going Beyond the Grand Mean: Subgroup Analysis in Meta‐Analysis of Randomised Trials
Smith, G. D., & Egger, M. (2001) · Wiley eBooks · doi:10.1002/9780470693926.ch8 · Cited by 34
Der Patient mit Ornithintranscarbamylasemangel
Schmidt, J. L., Schroth, M. A., Irouschek, A., Birkholz, T., Kurzai, M., Kröber, S., Meisner, M., & Albrecht, S. (2005) · Der Anaesthesist · doi:10.1007/s00101-005-0911-5 · Cited by 23
Cited by
Weiss, S. L., Peters, M. J., Alhazzani, W., Agus, M. S. D., Flori, H. R., Inwald, D. P., Nadel, S., Schlapbach, L. J., Tasker, R. C., Argent, A. C., et al. (2020) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000002198 · Cited by 1,228
Tamma, P. D., Heil, E. L., Justo, J. A., Mathers, A. J., Satlin, M. J., & Bonomo, R. A. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae403 · Cited by 1,191
Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad428 · Cited by 740
Weiss, S. L., Peters, M. J., Alhazzani, W., Agus, M. S. D., Flori, H. R., Inwald, D. P., Nadel, S., Schlapbach, L. J., Tasker, R. C., Argent, A. C., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-019-05878-6 · Cited by 606
Slimings, C., & Riley, T. V. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt477 · Cited by 581
Metadata
- Authors
- Brown, K. A., Khanafer, N., Daneman, N., & Fisman, D. N.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2013-05
- Volume
- 57
- Issue
- 5
- Pages
- 2326-2332
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W1974883267
- Cited by
- 587
- References
- 38
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.